Anti-CMV-IgG Positivity of Donors Is Beneficial for alloHSCT Recipients with Respect to the Better Short-Term Immunological Recovery and High Level of CD4+CD25high Lymphocytes

Lignende værker

• The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow
  af: Lange, Andrzej, et al.
  Udgivet: (2018)
• Correction: The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow
  af: Lange, Andrzej, et al.
  Udgivet: (2018)
• Cytokine Overproduction and Immune System Dysregulation in alloHSCT and COVID-19 Patients
  af: Lange, Andrzej, et al.
  Udgivet: (2021)
• CMV Serostatus of Donor-Recipient Pairs Influences the Risk of CMV Infection/Reactivation in HSCT Patients
  af: Jaskula, Emilia, et al.
  Udgivet: (2012)
• Fifteen-year follow-up of patients with critical limb ischaemia after local cellular therapy: the long-term positive effect is due to the presence of CD45– CD34– and CD34+ cells in the inoculum
  af: Lange, Andrzej, et al.
  Udgivet: (2019)